Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Current Leases (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Current Leases for 6 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Current Leases fell 34.26% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, down 34.26% year-over-year, with the annual reading at $3.8 million for FY2025, 34.26% down from the prior year.
  • Current Leases for Q4 2025 was $3.8 million at Relay Therapeutics, up from $3.6 million in the prior quarter.
  • The five-year high for Current Leases was $5.9 million in Q1 2025, with the low at $1.6 million in Q1 2021.
  • Average Current Leases over 5 years is $3.9 million, with a median of $4.4 million recorded in 2022.
  • The sharpest move saw Current Leases soared 221.32% in 2022, then tumbled 34.26% in 2025.
  • Over 5 years, Current Leases stood at $1.8 million in 2021, then soared by 131.89% to $4.3 million in 2022, then increased by 16.09% to $5.0 million in 2023, then increased by 15.37% to $5.7 million in 2024, then crashed by 34.26% to $3.8 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $3.8 million, $3.6 million, and $3.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.